Nils Löfgren
Nils Löfgren was born on 18 August 1913 and died on 21 January 1967. Löfgren was a Swedish chemist who developed the anaesthetic Lidocaine (under the name Xylocaine) in 1943 and isolated the purine nucleoside antibiotic nebularine in 1953.
At the time Löfgren developed Lidocaine, he had recently finished his licentiate degree and was teaching organic chemistry at the Stockholm University. He and his co-worker Bengt Lundqvist sold the rights to Xylocaine to the Swedish pharmaceutical company Astra AB.[1] In 1948, Löfgren completed his doctorate, and the title of his dissertation was Studies on local anesthetics: Xylocaine: a new synthetic drug.[2] He later became professor of organic chemistry at the Stockholm University.[1]
In 1953, alongside Swedish chemist Björn Lüning and veterinary bacteriologist Harry Hedström, Löfgren succesfully isolated nebularine from the Clitobyde nebularis fungus.[3]
References
- 1 2 Early history of the Department of Analytical Chemistry at the Stockholm University Archived 2011-01-29 at the Wayback Machine (in Swedish)
- ↑ Libris database
- ↑ Löfgren, Nils; Lüning, Björn; Hedström, Harry; Burris, R. H. (1954). "The Isolation of Nebularine and the Determination of its Structure". Acta Chemica Scandinavica. 8: 670–680. doi:10.3891/acta.chem.scand.08-0670. ISSN 0904-213X.